I still think Frank Richmond selling caused loss of faith coupled with little guidance around revenue. Might have to wait until the quarterly in Jan. But completely undervalued when compared to BPF and MOQ. Unless they're overvalued.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025